Rutjes Saskia A, Vennis Iris M, Wagner Edith, Maisaia Vakhtang, Peintner Lukas
Laboratory for Zoonoses and Environmental Microbiology, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Section of Experimental Virology, Institute of Medical Microbiology, Jena University-Hospital, Jena, Germany.
Front Bioeng Biotechnol. 2023 Mar 1;11:1117316. doi: 10.3389/fbioe.2023.1117316. eCollection 2023.
As the world continues to battle the SARS-CoV-2 pandemic, it is a stark reminder of the devastation biological threats can cause. In an unprecedented way the global community saw a massive surge in the demand for diagnostic capacities, which had a substantial impact on biosafety and biosecurity. Laboratories had to cope with a surge in laboratory testing capacity, while resources and training possibilities were limited. In addition, the pandemic highlighted the impact biological threats can have, thereby giving rise to new dialogue about biosecurity and new biological threats. This paper aims to highlight some of the most pressing issues regarding biosafety and biosecurity observed during the COVID-19 pandemic with special focus on low and lower middle-income countries. The authors provide lessons learned, tools and recommendations to improve future biosafety and biosecurity and increase preparedness for the next global health crisis.
随着世界继续抗击新冠疫情,这强烈提醒人们生物威胁可能造成的破坏。全球社会以前所未有的方式见证了诊断能力需求的大幅激增,这对生物安全和生物安保产生了重大影响。实验室不得不应对实验室检测能力的激增,而资源和培训机会却很有限。此外,疫情凸显了生物威胁可能产生的影响,从而引发了关于生物安保和新生物威胁的新对话。本文旨在强调在新冠疫情期间观察到的一些关于生物安全和生物安保的最紧迫问题,特别关注低收入和中低收入国家。作者提供了经验教训、工具和建议,以改善未来的生物安全和生物安保,并增强对下一次全球卫生危机的防范能力。